VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,691 | -55.7% | 1,354,400 | +15.9% | 0.02% | -46.3% |
| Q2 2023 | $28,653 | +6.1% | 1,168,100 | +0.7% | 0.04% | +13.9% |
| Q1 2023 | $27,005 | +0.8% | 1,160,500 | +9.6% | 0.04% | -2.7% |
| Q4 2022 | $26,788 | -99.9% | 1,058,400 | -30.0% | 0.04% | -9.8% |
| Q3 2022 | $29,161,000 | +103.6% | 1,512,494 | +168.9% | 0.04% | +141.2% |
| Q2 2022 | $14,324,000 | +490.0% | 562,400 | +495.8% | 0.02% | +466.7% |
| Q1 2022 | $2,428,000 | +0.2% | 94,400 | +63.0% | 0.00% | 0.0% |
| Q4 2021 | $2,424,000 | -36.0% | 57,900 | -27.7% | 0.00% | -40.0% |
| Q2 2021 | $3,787,000 | +88.9% | 80,102 | +36.9% | 0.01% | +150.0% |
| Q1 2020 | $2,005,000 | – | 58,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |